StopDown
RISA Labs logo
Funding · 14 January 2026RISA Labs$11.1MAI operating system for oncologyrisalabs.ai ↗

RISA Labs raises $11.1M Series A for oncology AI

By · Editor ·

Series APalo AltoFounded June 2024
  • RISA Labs builds an AI operating system that automates administrative tasks for cancer care
  • It raised $11.1M in Series A co-led by Cencora Ventures and Optum Ventures
  • The platform freed up 80% of admin staff time at one partner site and cut denials by 40%

What happened

  • RISA Labs has closed an $11.1M Series A funding round.
  • The round was co-led by Cencora Ventures and Optum Ventures.
  • Oncology Ventures, Z21 Ventures, and John Simon (via Ventureforgood) also participated.
  • The company builds an AI operating system for oncology that automates patient access, benefits verification, and prior authorization.
  • Its product, BOSS Console, acts as a command control panel for cancer clinics and health systems.
  • The platform connects to EMR, payer, and benefits systems and uses AI agents to read, reason, and act across them.
  • Funds will be used to accelerate deployment across US cancer clinics, health systems, specialty pharmacies, and infusion networks.

Why it matters

  • Healthtech was among the top 10 funded sectors in the Indian startup ecosystem in 2025, with over $700M across 54 deals.
  • RISA Labs previously raised a $3.5M seed round led by Flipkart co-founder Binny Bansal in April 2025.
  • The company was founded in June 2024 and is headquartered in Palo Alto, California.

The business

  • RISA Labs provides an AI operating system for oncology that automates administrative workflows.
  • Its BOSS Console is a command control panel for mission-critical institutions like cancer clinics and health systems.
  • The platform connects to EMR, payer, and benefits systems and other systems of record.
  • AI agents read, reason, and act across systems, adapting in real time to changing forms, rules, and interfaces.
  • Target customers are cancer clinics, health systems, specialty pharmacies, and infusion networks in the US.
  • At one partner site, the platform freed up ~80% of administrative staff time, reduced denials by up to 40%, and achieved a 97.8% first-pass approval rate.
  • Patient authorizations are filed within 24 hours of request, on track to drop below 2 hours from an average 8-day backlog.
  • In nine months, partner institutions expanded from initial deployment to second and third workflows.

The founders

Kshitij Jaggi

CEO
  • Kshitij Jaggi is the CEO of RISA Labs.
  • He is an IIT Kanpur alumnus.
  • He co-founded healthcare startup Urban Health.

Kumar Shivang

CTO
  • Kumar Shivang is the CTO of RISA Labs.
  • He is an IIT Kanpur alumnus.
  • He co-founded healthcare startup Urban Health.

Who put in money

  • Cencora Ventures co-lead — Corporate venture capital fund of Cencora.
  • Optum Ventures co-lead
  • Oncology Ventures participated
  • Z21 Ventures participated
  • John Simon participated — Co-founder of General Catalyst, investing via Ventureforgood entity.
  • Binny Bansal existing — Flipkart co-founder, led the seed round and continued backing in Series A.

In numbers

~80%Administrative staff time freed up
up to 40%Denials reduced
97.8%First-pass approval rate
within 24 hoursPatient authorization filing time
more than 20FTEs repurposed at one partner site
$3.5MSeed round amount · 2025

What happens next

  • Accelerate deployment across US cancer clinics, health systems, specialty pharmacies, and infusion networks.
  • Go deeper in oncology, partner with ecosystem leaders, and expand AI-driven workflows across the full continuum of cancer care.
  • Extend capabilities to specialty pharmacy operations via the BOSS Console.

Earlier rounds

  • April 2025 · Seed · $3.5M · led by Binny Bansal

Words to know

Series A
The first significant round of venture capital funding, typically used to scale the business.
EMR
Electronic Medical Record – a digital version of a patient's medical history.
Prior authorization
Approval from a health insurance plan before a medical service or prescription is provided.
FTE
Full-Time Equivalent – a unit that indicates the workload of an employed person.

The numbers around it

Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 14 January 2026 →

Is this RISA Labs? Get your “Featured on StopDown” badge →